I received my B.S. in biology from the University of Texas San Antonio and have been with the Department of Internal Medicine, Division of Cardiology since 1999. My main role in the lab involves applying a bioinformatics approach to decode complex biological data into molecular and cellular mechanisms and further validating these with classical and state-of-the-art scientific techniques. Current focuses include biocompatibility studies of biomaterials injected into mouse myocardium as well as the use of biomaterials for myocardial delivery of therapeutics such as microRNA mimics/inhibitors and cardiogenic small molecules.
Sergii Kyrychenko, Ph.D.
I received my Ph.D. in 2010 in pharmacology from the Institute of Pharmacology and Toxicology, Kyiv, Ukraine. Afterward, I studied mechanisms of dystrophic cardiomyopathy development in the Shirokova Lab at Rutgers University, N.J., USA. In May 2014, I joined the Schneider Lab. My research interests focus on molecular mechanisms of cardiac regeneration and developing biomaterials (alginate, myomatrix)-based approaches for improving failing heart function and as delivery platforms for pharmacological agents and/or stem cells to the myocardium.
Viktoriia Kyrychenko, Ph.D.
I received my Ph.D. in biochemistry from Taras Shevchenko Kyiv National University and Bogomolets Institute of Physiology, Kyiv, Ukraine in 2011. In 2011-2014, as a postdoctoral researcher, I studied mechanisms of Ca2+ signaling and mitochondrial function in dystrophic myocardium in the N. Shirokova lab, Rutgers University, N.J., USA. In May 2014, I joined the Schneider Lab, where my research interest is focused on employing induced pluripotent stem cells (iPSCs) for studying Chagas heart disease and developing new therapeutic strategies for its treatment as well as for small molecule inhibitors screening as potential regulators of cardiac differentiation.
Sara Slabisak, M.D.
A 'Lone Star State' native, I proudly grew up in San Antonio, Texas, where I attended Communications Arts (Magnet) High School and graduated in the top 10 of my class (9/1200). In the fall of 2005, I moved to Houston, Texas, to attend William Marsh Rice University where I completed a bachelor's degree in biochemistry and cell biology, graduating with a "Fellows Emeritus" distinction for my service as a university academic fellow in 2009. I am a recent medical graduate of The University of Texas Medical School at Houston. I joined the Schneider Lab in October 2014. I am responsible for technology and media development, laboratory work with induced pluripotent stem cells (iPSCs) and their use in developing cellular therapies for chemotherapy-induced cardiotoxicity, as well as Chagas disease, and am currently working on refining my research interests and focus.